91
94.Fewer complications result from a video-assisted approach to anatomic resection of clinical stage I lung cancer / D.J. Boffa, A. Dhamija, A.S. Kosinski et al. // J. Thorac. Cardiovasc. Surg. – 2014. – V. 148. – P. 637–643.
95.Fleisher, L.A. Perioperative beta blockade: where do we go from here? / L.A. Fleisher, D. Poldermans // Lancet. – 2008. – V. 371. – P. 1813–1814.
96.Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE IV study / O. Schouten, D. Poldermans, L. Visser et al. // Am. Heart. J. – 2004. – V. 148. – P. 1047–1052
97.Funatogawa, I. Trends in smoking and lung cancer mortality in Japan, by birth cohort, 1949-2010 / I. Funatogawa, T. Funatogawa, E. Yano // Bull. World. Health. Organ. – 2013. – V. 91. – P. 332–340.
98.Global cancer statistics / A. Jemal, F. Bray, M.M. Center et al. // CA. Cancer. J. Clin. – 2011. – V. 61 (2). – P. 69–90.
99.Global cancer statistics, 2012 / L.A. Torre, F. Bray, R.L. Siegel et al. // CA. Cancer. J. Clin. – 2015. – V. 65. – P. 87–108.
100.He surgical management of carcinoma of the lung; a study of the cases treated at the Massachusetts General Hospital from 1930 to 1950 / E.D. Churchill, R.H. Sweet, L. Soutter, J.G. Scannell // J. Thorac. Surg. – 1950. - V. 20 (3). - P. 349-365.
101.Higher versus standard pre-operative radiation in the trimodality treatment of stage IIIA lung cancer / S.C. Bharajwat, E. Vallieres, C.L. Wilshire et al. // Ann. Thorac. Surg. – 2015. – V. 100. – P. 207-214.
102.Historical notes on lung cancer before and after Graham’s successful pneumonectomy in 1933 / L.A. Brewer // Am. J. Surg. Pathol. – 1982. – V. 143. – P. 650-659.
103.Hyperfractionated and accelerated radiotherapy in non-small cell lung cancer / K. Haslett, C. Pöttgen, M. Stuschke et al. // J. Thorac. Dis. – 2014. – V. 6 (4). – P. 328–335.
Рекомендовано к изучению сайтом МедУнивер - https://meduniver.com/
92
104.Imaging of postoperative complications following surgery for lung cancer / S. Bommart, J.P. Berthet, G. Durand et al. // Diagn. Interv. Imaging. - 2017. – V. 98. – P. 11-20.
105.Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer / M. Koshy, S.A. Fedewa, R. Malik et al. // J. Thorac. Oncol. – 2013. – № 8. – P. 915–922.
106.Incidence and risk factors of persistent air leak after major pulmonary resection and use of chemical pleurodesis / M. Liberman, A. Muzikansky, С.D. Wright et al. // Ann. Thorac. Surg. – 2010. – V. 89. – P. 891-897; discussion 7-8.
107.Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation / A.A. Vaporciyan, K.W. Merriman, F. Ece et al. // Ann. Thorac. Surg. – 2002. – V. 73. – P. 420–425.
108.Induction chemoradiation is not superior to induction chemotherapy alone in stage IIIA lung cancer / A.A. Shah, M.F. Berry, C. Tzao et al. // Ann. Thorac. Surg. – 2012. – V. 93. – P. 1807–1812.
109.Influence of postoperative infectious complications on long-term survival of lung cancer patients: a population-based cohort study / A. Andalib, A.V. RamanaKumar, G. Bartlett et al. // J. Thorac. Oncol. - 2013. – V. 8. – P. 554-561.
110.Intracostal sutures decrease the pain of thoracotomy / R.J. Cerfolio, T.N. Price, A.S. Bryant et al. // Ann. Thorac. Surg. – 2003. – V. 76. – P. 407-412.
111.Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with stage I non-small-cell lung cancer? / S. Mahmood, H. Bilal, C. Faivre-Finn, R. Shah // Interact. Cardiovasc. Thorac. Surg. – 2013. – V. 17 (5).
– P. 845-53.
112.Limited resection for the treatment of patients with stage IA lung cancer / J.P. Wisnivesky, C.I. Henschke, S. Swanson et al. // Ann. Surg. - 2010. – V. 251 (3). – P. 550-554.
113.Lobectomy by video-assisted thoracic surgery vs muscle-sparing thoracotomy for stage I lung cancer: a critical evaluation of shortand long-term
93
outcomes / A.M. Kuritzky, B.I. Aswad, R.N. Jones, T. Ng // J. Am. Coll. Surg. – 2015.
–V. 220. – P. 1044-1053.
114.Local failure in resected N1 lung cancer: implications for adjuvant therapy / K.A. Higgins, J.P. Chino, M. Berry et al. // Int. J. Radiat. Oncol. Biol. Phys. – 2012. – V. 83 (2). – P. 727-733.
115.Long-Term Prognostic Impact of Severe Postoperative Complications After Lung Cancer Surgery / S. Okada, J. Shimada, D. Kato et al. // Ann. Surg. Oncol. – 2019.
–V. 26 (1). – P. 230-237.
116.Low molecular weight heparin (LMWH) for primary thrombo-prophylaxis in patients with solid malignancies - systematic review and meta-analysis / I. I. BenAharon, S.M. Stemmer, L. Leibovici et al. // Acta. Oncologica. - 2014. – V. 53. – P. 1230–1237.
117.Lung cancer incidence trends by gender, race and histology in the United States, 1973-2010 / R. Meza, C. Meernik, J. Jeon, M.L. Cote // PLoS. One. – 2015. – № 10. – P. e0121323
118.Lyman, A. Historical notes on lung cancer before and after Graham's successful pneumonectomy in 1933 / A. Lyman // The American J. of Surgery. – 1982. - V. 143, Issue 6. – P. 650-659.
119.Lymph node evaluation by open or video-assisted approaches in 11,500 anatomic lung cancer resections / D.J. Boffa, A.S. Kosinski, S. Paul et al. // Ann. Thorac. Surg. – 2012. – V. 94. – P. 347–353.
120.Lymphatic Uptake of Liposomes after Intraperitoneal Administration Primarily Occurs via the Diaphragmatic Lymphatics and is Dependent on Liposome Surface Properties. / L.G. Properties, S. Han, I. Inocencio et al. // Mol. Pharm. – 2019.
–V. 16 (12). – P. 4987-4999.
121.Mahajan, A.K. Isolation of persistent air leaks and placement of intrabronchial valves / A.K. Mahajan, D.C. Doeing, D.K. Hogarth // J. Thorac. Cardiovasc. Surg. – 2013. – V. 145. – P. 626-630.
Рекомендовано к изучению сайтом МедУнивер - https://meduniver.com/
94
122.Malanchuk, V. Modern treatment methods in the maxilla-facial area and neck / V. Malanchuk, A. Sidoryako, S. Vardzhapetian // Georgian. Med. News. – 2019.
–V. 294. – P. 57-61.
123.Marinho, F.C. Hypercoagulability and lung cancer / F.C. Marinho, T.Y. Takagaki // J. Bras. Pneumol. – 2008. – V. 34. – P. 312–322.
124.Mehta, R.S. Race and health disparities in patient refusal of surgery for early-stage non-small cell lung cancer: a SEER cohort study / R.S. Mehta, D. Lenzner, A. Argiris // Ann. Surg. Oncol. – 2012. – V. 19. – P. 722–727.
125.Merritt, R.E. Lymph node evaluation achieved by open lobectomy compared with thoracoscopic lobectomy for N0 lung cancer / R.E. Merritt, C.D. Hoang, J.B. Shrager // Ann. Thorac. Surg. – 2013. – V. 96. – P. 1171–1177.
126.Minimally invasive surgery in cancer. Immunological response / A.C. Bobocea, B. Trandafir, C. Bolca, I. Cordoş // Chirurgia (Bucur). – 2012. – V. 107 (2). – P. 154-157.
127.Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer / D. Lardinois, H. Suter, H. Hakki et al. // Ann. Thorac. Surg. – 2005. – V. 80 (1).
–P. 268-274; discussion 274-5.
128.Ninety-day costs of video-assisted thoracic surgery versus open lobectomy for lung cancer / F. Farjah, L.M. Backhus, T.K. Varghese et al. // Ann. Thorac. Surg. – 2014. – V. 98. – P. 191-196.
129.Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer / J. Brahmer, K.L. Reckamp, P. Baas et al. // N. Engl. J. Med. – 2015. – V. 373. – P. 123–135.
130.Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival / J.M. Varlotto, A.N. Yao, M.M. DeCamp et al. // Int. J. Radiat. Oncol. Biol. Phys. – 2015. – V. 91 (40). – P. 765-773.
131.Nodal upstaging is more common with thoracotomy than with VATS during lobectomy for early-stage lung cancer: an analysis from the National Cancer Data
95
Base / R.L. Medbery, T.W. Gillespie, Y. Liu Y et al. // J. Thorac. Oncol. – 2016. –
№11. – P. 222–233.
132.Okada, M. Radical sublobar resection for small-diameter lung cancers / M. Okada // Thorac. Surg. Clin. – 2013. – V. 23. – P. 301-311.
133.Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study / Y. Tsutani, Y. Miyata, H. Nakayama et al. // J. Thorac. Cardiovasc. Surg. – 2013. – V. 146. – P. 358-364.
134.Outcome after video-assisted thoracoscopic surgery and open pulmonary lobectomy in patients with low VO2 max: a case-matched analysis from the ESTS database / S.S. Begum, K. Papagiannopoulos, P.E. Falcoz et al. // Eur. J. Cardiothorac. Surg. – 2016. – V. 49 (4). – P. 1054-1058.
135.Oxnard, G.R. New targetable oncogenes in non-small-cell lung cancer / G.R. Oxnard, A. Binder, P.A. Jänne // J. Clin. Oncol. – 2013. – V. 31. – P. 1097–1104.
136.Pembrolizumab for the treatment of non-small-cell lung cancer / E.B. Garon, N.A. Rizvi, R. Hui et al. // N. Engl. J. Med. – 2015. – V. 372. – P. 2018–2028.
137.Poor preoperative patient-reported quality of life is associated with complications following pulmonary lobectomy for lung cancer / C. Pompili, G. Velikova, J. White et al. // Eur. J. Cardiothorac. Surg. - 2017. – V. 51. – P. 526–531.
138.Porhanov, V. Simultaneous operation for malignant pathology of heart and lung through sternotomy / V. Porhanov, I. Polyakov, K. Barbukhatti // Supplement to Journal of Thoracic. Oncology. – 2011. – V. 6 (6). – P. 5871.
139.Postoperative complications after thoracic surgery for lung cancer/ J.A. Rotman, A.J. Plodkowski, S.A. Hayes et al. // Clin. Imaging. – 2015. – V. 39. - P. 735749.
140.Postoperative pneumonia after major lung resection / O. Schussler, M. Alifano, H. Dermine et al. // Am. J. Respir. Crit. Care. Med. – 2006. – V. 173. – P. 11611169.
Рекомендовано к изучению сайтом МедУнивер - https://meduniver.com/
96
141.Postpneumonectomy empyema: results after the Clagett procedure / S. Zaheer, M.S. Allen, S.D. Cassivi et al. // Ann. Thorac. Surg. – 2006. – V. 82. – P. 279286.
142.Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy / S. Saisho, K. Yasuda, A. Maeda et al. // Interact. Cardiovasc. Thorac. Surg. – 2013. – V. 16. – P. 166172.
143.Poullis, M. Treatment outcomes in stage I lung cancer: a comparison of surgery and stereotactic body radiation therapy / M. Poullis // J. Thorac. Oncol. – 2016.
–№11. – P. e64–e65.
144.Predictors and outcomes of venous thromboembolism in hospitalized lung cancer patients: A Nationwide Inpatient Sample database analysis / C.E. Steuer, M. Behera, S. Kim et al. // Lung. cancer. – 2015. – V. 88. – P. 80–84.
145.Preoperative computed tomography-guided microcoil localization of small peripheral pulmonary nodules: a prospective randomized controlled trial / R.J. Finley, J.R. Mayo, K. Grant et al. // J. Thorac. Cardiovasc. Surg. – 2015. – V. 149. – P. 26-31.
146.Preoperative evaluation of lung cancer patients / M.Licker, F. Triponez, J. Diaper, W. Karenovics, P.O. Bridevaux // Curr. Anesthesiol Rep. – 2014. – V. 4. – P. 124–134.
147.Promoting intestinal lymphatic transport targets a liver-X receptor (LXR) agonist (WAY-252,623) to lymphocytes and enhances immunomodulation / E. Cao, A. Lindgren, S. Martinsson et al. // J. Control. Release. - 2019. – V. 296. – P. 29-39.
148.Pulmonary embolism, myocardial infarction, and ischemic stroke in lung cancer patients: Results from a longitudinal study / M.P.P. van Herk-Sukel, S. Shantakumar, Beest F.J.A. Penning-van et al. // Lung. – 2013. - V. 191. – P. 501–509
149.Pulmonary function tests do not predict pulmonary complications after thoracoscopic lobectomy / M.F. Berry, N.R. Villamizar-Ortiz, B.C. Tong et al. // Ann. Thorac. Surg. – 2010. – V. 89 (4). – P. 1044-1051.
97
150.Quality assessment using EQ-5D-5L after lung surgery for non-small cell lung cancer (NSCLC) patients / R. Koide, A. Kikuchi, M. Miyajima et al. // Gen. Thorac. Cardiovasc. Surg. – 2019. – V. 67. – P. 1056–1061.
151.Radio-guided localization and resection of small or ill-defined pulmonary lesions / D. Galetta, M. Bellomi, C. Grana, L. Spaggiari // Ann. Thorac. Surg. – 2015. – V. 100. – P. 1175–1180.
152.Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 less than hilar) non-small cell carcinoma / G.E. Darling, M.S. Allen, P.A. Decker et al. // J. Thorac. Cardiovasc Surg. – 2011. – V. 141. – P. 662-670.
153.Risk factors for 30-day mortality after resection of lung cancer and prediction of their magnitude / T.E. Strand, H. Rostad, R.A. Damhuis, J. Norstein // Thorax. - 2007. - V. 62 (11). - P. 991-997.
154.Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: Patient selection criteria for adjuvant chemotherapy according to the 7th edition TNM classification / R. Maeda, J. Yoshida, G. Ishii et al. // Chest. –2011. – V. 140. – P. 1494-1502.
155.Risk factors of postoperative pneumonia after lung cancer surgery / J.Y. Lee, S.M. Jin, C.H. Lee et al. // J. Korean. Med. Sci. – 2011. – V. 26. – P. 979-984.
156.Salah, S. Metastasectomy for extra-cranial extra-adrenal non-small cell lung cancer solitary metastases: systematic review and analysis of reported cases / S. Salah, T. Tanvetyanon, S. Abbasi // Lung. Cancer. – 2012. – V. 75. – P.9-14.
157.Satava, R.M. Identification and reduction of surgical error using simulation / R.M. Satava // Min. Invas. Therapy. Allied. Technol. - 2005. - V. 14 (4–5). - P. 257– 261.
158.Segmental resection for lung cancer. A fifteen-year experience / R.J. Jensik, L.P. Faber, F.J. Milloy et al. // J. Thorac. Cardiovasc. Surg. – 1973. – V. 66. – P. 563572.
159.Segmentectomy as a safe and equally effective surgical option under complete video-assisted thoracic surgery for patients of stage I non-small cell lung
Рекомендовано к изучению сайтом МедУнивер - https://meduniver.com/
98
cancer/ X. Zhao, L. Qian, Q. Luo, J. Huang // J. Cardiothorac. Surg. – 2013. – № 8. – P. 116-118.
160.Siegel, R. Cancer Statistics, 2012 / R. Siegel, D. Naishadham, A. Jemal // CA Cancer. J. Clin. – 2013. – V. 63. – P. 11–30.
161.Sihoe, A.D. Reasons not to perform uniportal VATS lobectomy / A.D. Sihoe // J. Thorac. Dis. – 2016. – № 8. – P. S333–S343.
162.Single-incision thoracoscopic lobectomy and segmentectomy with radical lymph node dissection / B.Y. Wang, C.C. Tu ,C.Y. Liu et al. // Ann. Thorac. Surg. – 2013. – V. 96. – P. 977–982.
163.Single-incision versus multiple-incision thoracoscopic lobectomy and segmentectomy: a propensity-matched analysis / B.Y. Wang, C.Y. Liu, P.K. Hsu et al.
//Ann. Surg. – 2015. – V. 261. – P. 793-799.
164.Single-incision video-assisted thoracoscopic lobectomy: initial results / D. Gonzalez-Rivas, M. Paradela, E. Fieira et al. // J. Thorac. Cardiovasc. Surg. – 2012. – V. 143. – P. 745–747.
165.Single-port video-assisted thoracoscopic anatomic segmentectomy and right upper lobectomy / D. Gonzalez-Rivas, E. Fieira, L. Mendez, J. Garcia // Eur. J. Cardiothorac. Surg. – 2012. – V. 42. – P. e169–e171.
166.Smetana, G.W. Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians / G.W. Smetana, V.A. Lawrence, J.E. Cornell // Ann. Intern. Med. – 2006. – V. 144. - P. 581-595.
167.Smoking status at diagnosis and histology type as determinants of long-term outcomes of lung cancer patients / M. Poullis, J. McShane, M. Shaw et al. // Eur. J. Cardiothorac. Surg. – 2013. – V. 43. – P. 919–924.
168.Souilamas, R. Mediastinal lymphatic efferents from the diaphragm / R. Souilamas, G. Hidden, M. Riquet // Surg. Radiol. Anat. – 2001. – V. 23. – P. 159-162.
169.Stage at diagnosis and early mortality from cancer in England / S. McPhail, S. Johnson, D. Greenberg et al. // Br. J. Cancer. – 2015. – V. 112. – P. S108–S115.
99
170.Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada / S.K. Vinod, E. Wai, C. Alexander et al. // J. Thorac. Oncol. – 2012. – V. 7 (7). – P.1155-1163.
171.Strasberg, S.M. The accordion severity grading system of surgical complications / S.M. Strasberg, D.C. Linehan, W.G. Hawkins // Ann. Surg. - 2009. – V. 250 (2). – P. 177-186.
172.Subclavian artery resection and reconstruction for thoracic inlet cancers / E. Fadel, A. Chapelier, E. Bacha et al. // J. Vasc. Surg. – 1999. – V. 29. – P. 581–588.
173.Surgical outcomes and complications of pneumonectomy after induction therapy for non-small cell lung cancer / H. Kayawake, N. Okumura, K. Yamanashi et al. // Gen. Thorac. Cardiovasc. Surg. – 2018. – V. 66 (11). – P. 658-663.
174.Systematic classification of morbidity and mortality after thoracic surgery / A.J. Seely, J. Ivanovic, J. Threader et al. // Ann. Thorac. Surg. – 2010. – V. 90 (3). – P. 936-942.
175.Techniques to define segmental anatomy during segmentectomy / H. Oizumi, H. Kato, M. Endoh et al. // Ann. Cardiothorac. Surg. – 2014. – № 3. – P. 170175.
176.Ten-year experience on 644 patients undergoing single-port (uniportal) video-assisted thoracoscopic surgery / G. Rocco, N. Martucci, C. La Manna et al. // Ann. Thorac. Surg. – 2013. – V. 96. – P. 434–438.
177.The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients / M.E. Charlson, R.E. Charlson, J.C. Peterson et al. // J. Clin. Epidemiol. – 2008. – V. 61. – P. 1234-1240.
178.The cortisol stress response induced by surgery: A systematic review and meta-analysis / A. Prete, Q. Yan, K. Al-Tarrah, H.K. Akturk et al. // Clin. Endocrinol. (Oxf). - 2018. - V. 89 (5). - P. 554-567.
179.The impact of cardiovascular comorbidity on the outcome of surgery fro stage I and II nonsmall-cell lung cancer / V. Ambrogi, E. Pompeo, S. Elia et al. // Eur. J. Cardiothorac. Surg. –2003. – V. 23. – P. 811-817.
Рекомендовано к изучению сайтом МедУнивер - https://meduniver.com/
100
180.The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis / T. Naruke, T. Goya, R. Tsuchiya, K. Suemasu // Ann. Thorac. Surg. – 1988. – V. 46. – P. 603–610.
181.The influence of provider characteristics on resection rates and survival in patients with localized non-small cell lung cancer / W.W. Li, O. Visser, D.T. Ubbink et al. // Lung. Cancer. – 2008. – V. 60. – P. 441–451.
182.The stage classification of lung cancer: diagnosis and management of lung cancer, 3rd edition: ACCP evidence-based clinical practice guidelines / F.C. Detterbeck, S.Z. Lewis, R. Diekemper et al. // Chest. – 2013. – V. 143 (5). – P. 191-210.
183.The Thoracic Surgery Scoring System (Thoracoscore): risk model for inhospital death in 15,183 patients requiring thoracic surgery / P.E. Falcoz, M. Conti, L. Brouchet et al. // J. Thorac. Cardiovasc. Surg. – 2007. – V. 133. – P. 325-332.
184.Therapeutic delivery to the peritoneal lymphatics: Current understanding, potential treatment benefits and future / A. Sarfarazi, G. Lee, S.A. Mirjalili et al. // Int. J. Pharm. – 2019. – V. 567. – P. 118456.
185.Thoracoscopic approach to lobectomy for lung cancer does not compromise oncologic efficacy / M.F. Berry, T.A. D'Amico, M.W. Onaitis et al. // Ann. Thorac. Surg.
– 2014. – V. 98. – P. 197–202.
186.Thoracoscopic lobectomy and segmentectomy for infectious lung disease / J.D. Mitchell, J.A. Yu, A. Bishop A et al. // Ann. Thorac. Surg. – 2012. – V. 93. – P. 1033–1039.
187.Thoracoscopic lobectomy is associated with acceptable morbidity and mortality in patients with predicted postoperative forced expiratory volume in 1 second or diffusing capacity for carbon monoxide less than 40% of normal / B.M. Burt, A.S. Kosinski, J.B. Shrager et al. // J. Thorac. Cardiovasc. Surg. – 2014. – V. 148 (1). – P. 19-28.
188.Thoracoscopic lobectomy is associated with lower morbidity compared with thoracotomy / N.R. Villamizar, M.D. Darrabie, W.R. Burfeind et al. // J. Thorac. Cardiovasc. Surg. – 2009. – V. 138 (2). – P. 419-425.